Gonorrhea in the Philippines: Everything You Need To Know

I. INTRODUCTION

             Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. It is one of the most common bacterial STIs worldwide and can infect the genitals, rectum, throat, and eyes. The infection is primarily transmitted through vaginal, anal, or oral sexual contact with an infected person. It may also be passed from a pregnant woman to her baby during childbirth. 

             Gonorrhea remains an important public health concern because many infections — particularly infections in women and infections of the throat—may cause few or no noticeable symptoms. A person may therefore have the infection and unknowingly transmit it to a sexual partner. 

             The World Health Organization (WHO) estimated that approximately 82.4 million new gonorrhea infections occurred among people aged 15-49 years worldwide in 2020. The burden was particularly high in the WHO African and Western Pacific Regions. 

             Although gonorrhea can be cured with appropriate antibiotics, treatment is becoming more challenging because N. gonorrhoeae has developed resistance to many antibiotics previously used against it. In recent WHO surveillance, resistance to important drugs such as ceftriaxone and cefixime has been increasing, making antimicrobial-resistance surveillance an essential part of gonorrhea control. 

II. WHAT IS GONORRHEA? 

          Gonorrhea is an infection caused by Neisseria gonorrhoeae, a bacterium that primarily infects mucous membranes. 

         Depending on the type of sexual exposure, the infection can occur in different parts of the body: 

• Urogenital tract - including the urethra and cervix 

• Rectum

• Throat

• Eyes

        Unlike HIV, gonorrhea is a bacterial infection. It can generally be cured with appropriate antibiotics treatment. However, treatment does not provide immunity. A person who has been successfully treated can become infected again if exposed to N. gonorrhoeae. 

        Gonorrhea can also occur together with other STIs. For this reason, people diagnosed with gonorrhea are generally advised to receive testing for other infections, including chlamydia, syphilis, and HIV. 

Gonorrhea Is Sometimes Called a “Silent” Infection 

         Not everyone with gonorrhea develops obvious symptoms. This is particularly important because a person who feels healthy may still carry and transmit the infection. 

         For this reason, absence of symptoms does not necessarily mean absence of gonorrhea.  

III. GONORRHEA IN NUMBERS: Global vs. Philippine Situation

Global Situation

         Gonorrhea remains one of the world’s major curable STIs. 

         WHO estimated approximately 82.4 million new gonorrhea infections among people aged 15-49 years in 2020. This included approximately 42.3 million infections among women and 40.1 million among men. The estimated global incidence was approximately 19 infections per 1,000 women and 23 infections per 1,000 men. 

         The WHO Western Pacific Region, which includes the Philippines, carries a substantial burden of gonorrhea. This makes prevention, diagnosis, treatment, and antimicrobial-resistance surveillance particularly relevant to countries in the region. 

Philippine Situation

          National gonorrhea statistics in the Philippines are not as comprehensive as the country’s HIV surveillance data. However, the Philippines has a long history of monitoring antimicrobial resistance in N. gonorrhoeae through the Antimicrobial Resistance Surveillance Program (ARSP). 

          A Philippine genomic surveillance study reported that ARSP has been collecting information on resistant gonorrhea since 1996. The study examined N. gonorrhoeae isolates collected in the Philippines during 2013-2014 and found resistance to several older antibiotics, including penicillin, ciprofloxacin, and tetracycline. 

         More recently, the Philippines has participated in WHO’s Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP). In WHO’s 2025 report covering 2024 data, the Philippines was among 13 countries contributing gonorrhea surveillance data. 

         WHO reported that, across participating EGASP countries, resistance to ceftriaxone increased from 0.8% in 2022 to 5% in 2024, while cefixime resistance increased from 1.7% to 11%. These figures are surveillance results across participating countries and should not be interpreted as the prevalence of resistance specifically among all gonorrhea infections in the Philippines. 

IV. WHO IS MOST AFFECTED?

          Gonorrhea can affect anyone who is sexually active. However, certain populations may experience a greater burden because of differences in sexual exposure, access to testing, and STI prevalence. 

Groups that may require particular attention include:

• Sexually active adolescents and young adults

• Men who have sex with men (MSM)

• Sex workers

• People with multiple or new sexual partners

• People with a previous STI 

• People whose sexual partners have an STI

           WHO’s updated STI recommendations highlight targeted gonorrhea and chlamydia screening in high-prevalence settings, particularly among sex workers, MSM, pregnant women, and sexually active adolescents and young people aged 10-24 years, where resources and local epidemiology support such screening. 

            It is important to emphasize that gonorrhea is not restricted to any particular gender or sexual orientation. Anyone exposed to the bacterium can become infected. 

V. HOW IS GONORRHEA TRANSMITTED?

            Gonorrhea is transmitted primarily through sexual contact with an infected person. 

1. Vaginal Sex

           The bacterium can be transmitted through sexual contact involving infected genital secretions. 

2. Anal Sex

         Gonorrhea can infect the rectum through anal sexual contact. Rectal infection may produce symptoms, but it can also occur without noticeable symptoms. 

3. Oral Sex

          Neisseria gonorrhoeae can infect the throat following oral sexual exposure. 

4. Mother-to-Children Transmission

           A pregnant woman with gonorrhea can transmit the infection to her baby during childbirth. The newborn can develop serious eye infection, known as gonococcal ophthalmia neonatorum. 

What Does NOT Normally Transmit Gonorrhea? 

Gonorrhea is not normally transmitted through casual everyday contact such as: 

• Hugging

• Handshaking

• Sharing food

• Sharing utensils

• Sitting beside an infected person

Sexual exposure is the primary means of transmission. 

VI. COMMON SYMPTOMS OF GONORRHEA

           Gonorrhea can produce different symptoms depending on the infected body site. However, some people do not experience noticeable symptoms. 

Gonorrhea in Men

           When symptoms occur, they commonly involve the urethra. 

Possible symptoms include: 

• Burning or pain when urinating 

• White, yellow, or green discharge from the penis

• Increased urinary discomfort

• Pain or swelling of the testicles

Urethral gonorrhea in men is more likely to produce noticeable symptoms than some other forms of gonorrhea. 

Gonorrhea in Women

Possible symptoms include: 

• Pain or burning when urinating 

• Increased vaginal discharge 

• Vaginal bleeding between menstrual periods

• Pelvic or lower abdominal discomfort

• Pain during sexual intercourse

However, women may have few or no recognizable symptoms, which can allow the infection to remain undetected. 

Rectal Gonorrhea

Rectal infection may cause: 

• Rectal discharge

• Anal itching

• Rectal soreness

• Bleeding

• Pain during bowel movements 

Some rectal infections may have no symptoms. 

Pharyngeal Gonorrhea

Gonorrhea of the throat may cause:

• Sore throat

• Throat irritation

• Redness

However, pharyngeal gonorrhea is frequently asymptomatic, making testing based on sexual exposure particularly important. 

VII. COMPLICATIONS OF UNTREATED GONORRHEA 

          Gonorrhea should not be ignored simply because symptoms are mild or absent. If untreated, the infection can spread and cause serious complications. 

Pelvic Inflammatory Disease

           In women, gonorrhea can spread from the cervix to the upper reproductive organs and contribute to pelvic inflammatory disease (PID). 

PID can damage the fallopian tubes and other reproductive organs. 

Possible consequences include:

• Chronic pelvic pain

• Infertility

• Ectopic pregnancy

Epididymitis 

           In men, gonorrhea can cause inflammation of the epididymis, a structure connected to the testicles. 

This may cause: 

• Pain

• Swelling

• Tenderness around the testicle 

Disseminated Gonococcal Infection

            In uncommon cases, N. gonorrhoeae can spread through the bloodstream.

This condition is called disseminated gonococcal infection (DGI). 

Possible manifestations include: 

• Fever

• Joint pain

• Joint swelling

• Arthritis 

• Skin lesions

DGI requires prompt medical treatment. 

Gonococcal Infection in Newborns

              An infected mother can transmit gonorrhea to her baby during childbirth. 

              The infection can cause severe inflammation of the newborn’s eyes. Without appropriate management, gonococcal eye infection can threaten the baby’s vision. 

VIII. WHY YOU SHOULD GET TESTED EARLY

               Early diagnosis is important because gonorrhea can exist without obvious symptoms. 

Testing can: 

• Identify an infection before complications occur 

• Reduce the chance of transmitting the infection to partners 

• Allow appropriate antibiotic treatment

• Help protect reproductive health 

• Identify infection at the correct anatomical site

IX. TYPES OF GONORRHEA TESTS AVAILABLE 

1. Nucleic Acid Amplification Tests (NAATs)

         NAATs detect genetic material from Neisseria gonorrhoeae. 

         They are widely used because they have high sensitivity and specificity and can be performed using several types of specimens. 

Possible specimens includes:

• Urine

• Vaginal swabs

• Cervical swabs

• Urethral swabs

• Rectal swabs

• Pharyngeal swabs

The appropriate specimen depends on the suspected site of infection. 

2. Culture

           Culture involves growing N. gonorrhoeae from a clinical specimen. 

           Although NAATs are widely used for diagnosis, culture remains especially important when antimicrobial susceptibility testing is needed. 

This is particularly relevant when: 

• Treatment failure is suspected 

• Antibiotic resistance is suspected

• Public-health surveillance is being performed

           Unlike a standard NAAT, culture can provide an isolate that can be tested to determine which antibiotics are effective against the bacterium. 

3. Gram Stain

            A Gram stain can sometimes help diagnose urethral gonorrhea in symptomatic men when characteristic intracellular gram-negative diplococci are observed. 

            However, Gram staining is not appropriate as a general replacement for molecular testing in every patient or anatomical site. 

X. WHAT TO DO IF YOU TEST POSITIVE OR NEGATIVE FOR GONORRHEA

If You Test Positive

             A positive test indicates that Neisseria gonorrhoeae has been detected. 

1. Seek Appropriate Treatment

            Gonorrhea requires antibiotic treatment prescribed by a healthcare professional. 

            Current CDC guidance recommends ceftriaxone administered intramuscularly for uncomplicated gonorrhea, with the dose depending on body weight. If chlamydia infection has not been excluded, additional treatment may be recommended. 

            Because antibiotic resistance is an increasing concern, people should not self-treat gonorrhea with leftover antibiotics or medication obtained without medical guidance. 

2. Inform Sexual Partners

             Recent sexual partners should be informed so they can receive appropriate evaluation, testing, and treatment. 

3. Avoid Sexual Activity Until Appropriate

              People receiving treatment should follow their healthcare provider’s instructions about when sexual activity can safely resume and should ensure that partners have also received appropriate treatment. 

4. Test for Other STIs

A diagnosis of gonorrhea should prompt consideration of testing for: 

• Chlamydia 

• Syphilis

• HIV

5. Follow-Up Testing

Follow-up depends on the anatomical site and treatment. 

           For example, CDC recommends a test of cure 7-14 days after treatment for pharyngeal gonorrhea, while routine test-of-cure is not generally required for uncomplicated urogenital or rectal gonorrhea treatment with recommended regimens. 

If You Tested Negative

A negative result means gonorrhea was not detected by the particular test performed. 

However, interpretation depends on:

• Timing of exposure

• Symptoms

• Specimen collected

• Anatomica site tested

• Whether there has been another exposure since testing

If someone has symptoms despite a negative result, they should consult a healthcare professional for further evaluation. 

A negative genital test, for example, does not necessarily rule out infection at another anatomical site that was not tested. 

XI. GONORRHEA AND ANTIBIOTIC RESISTANCE

          One of the most important issues that makes gonorrhea different from many other common bacterial STIs is its ability to develop resistance to antibiotics. 

          Over time, N. gonorrhoeae has developed resistance to multiple classes of antibiotics, including: 

• Sulfonamides

• Penicillins

• Tetracyclines 

• Fluoroquinolones

• Macrolides

• Some cephalosporins 

          This has progressively reduced the number of reliable treatment options. 

          WHO reported in 2025 that resistance to ceftriaxone and cefixime—the primary antibiotics monitored in its gonococcal surveillance program—had increased substantially between 2022 and 2024 across participating countries. 

The Philippine Connection

            Antimicrobial resistance in gonorrhea is not only a theoretical concern for the Philippines. 

            The country’s Antimicrobial Resistance Surveillance Program has monitored resistant gonorrhea since 1996. A genomic study of Philippine isolates collected in 2013-2014 found resistance to penicillin, ciprofloxacin, and tetracycline among several isolates. 

             The Philippines is also participating in WHO’s Enhanced Gonococcal Antimicrobial Surveillance Programme, which helps monitor resistance patterns and guide treatment policies. 

 

Why This Matters

Antibiotic-resistant gonorrhea can:

1. Make treatment more difficult. 

2. Increase the possibility of treatment failure.

3. Allow infection to persist and spread. 

4. Increase the risk of complications. 

5. Reduce the number of effective antibiotics available. 

This is why responsible antibiotic use and laboratory surveillance are critical to controlling gonorrhea. 

XII. PREVENTION AND MANAGEMENT

          Gonorrhea prevention involves reducing exposure, identifying infections early, treating infected individuals, and preventing reinfection. 

1. Use Condoms Correctly and Consistently 

          Condoms can reduce the risk of gonorrhea transmission when used correctly and consistently. 

2. Get Tested When Appropriate 

          Testing is particularly important for people with symptoms, known exposure, or risk factors that warrant screening. 

3. Communicate With Sexual Partners 

          Open communication about STI testing and sexual health can help partners make informed decisions. 

4. Treat Sexual Partners

          Treating partners helps prevent the infection from being passed back and forth. 

5. Complete Prescribed Treatment

           People diagnosed with gonorrhea should follow their healthcare provider’s treatment instructions. 

6. Avoid Self-Medicating

           Because N. gonorrhoeae can be resistant to multiple antibiotics, taking an appropriate antibiotic may fail to cure the infection and may contribute to further resistance. 

7. Strengthen STI Surveillance

            Laboratory surveillance is particularly important for gonorrhea because resistance patterns can change over time. WHO recommends strengthening gonococcal resistance surveillance as part of national STI programs. 

XIII. CONCLUSION

           Gonorrhea is a common sexually transmitted bacterial infection caused by Neisseria gonorrhoeae. It can affect the genital tract, rectum, throat, and eyes and can be transmitted through vaginal, anal, or oral sexual contact. 

           Although gonorrhea is curable with appropriate antibiotics, untreated infection can lead to serious complications. In women, it can contribute to pelvic inflammatory disease, infertility, and ectopic pregnancy. In men, it can cause complications such as epididymitis. In rare cases, the infection can spread throughout the body and cause disseminated gonococcal infection. 

           Gonorrhea can also be transmitted from an infected mother to her baby during childbirth, potentially causing serious eye infection in newborns. 

           The global burden of gonorrhea remains substantial, with WHO estimating 82.4 million new infections among people aged 15-49 in 2020. The Philippines is particularly relevant to global gonorrhea control because it is located in the Western Pacific Region and has participated in antimicrobial-resistance surveillance for N. gonorrhoeae for decades. 

            Perhaps the greatest challenge in gonorrhea control today is antimicrobial resistance. The bacterium has progressively developed resistance to several antibiotics, and WHO continues to report concerning increases in resistance to important treatment options. 

             Early testing, appropriate treatment, partner management, condom use, and responsible antibiotic use are therefore essential. 

             Gonorrhea is treatable, but it should not be ignored. Getting tested early and receiving the correct treatment can prevent complications, reduce transmission, and help protect the effectiveness of the antibiotics needed to treat this infection. 

 

 

REFERENCES

World Health Organization. (2025). More countries report rising levels of drug-resistant gonorrhoea, warns WHO. WHO – Drug-resistant gonorrhoea⁠

World Health Organization. (2025). Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): Gonorrhoea treatment optimization, 2025 report. WHO Western Pacific – EGASP 2025 Report⁠

World Health Organization Philippines. (2025). WHO expands guidance on sexually transmitted infections and reviews country progress on policy implementation. WHO Philippines – STI guidance⁠

Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines – Gonococcal Infections Among Adolescents and Adults. CDC – Gonorrhea Treatment Guidelines⁠

Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines – Diagnostic Considerations. CDC – STI Diagnostic Guidelines⁠

Jamoralin, M. C., et al. (2021). Genomic surveillance of Neisseria gonorrhoeae in the Philippines, 2013–2014. Western Pacific Surveillance and Response Journal. WHO Western Pacific – Philippine Gonorrhea Surveillance Study⁠